Skip to main content
Erschienen in: BMC Infectious Diseases 1/2024

Open Access 01.12.2024 | Case Report

Hemophagocytic lymphohistiocytosis and myopericarditis induced by campylobacter: a case report

verfasst von: Chia Hua Chang, Chih-Chuan Kao

Erschienen in: BMC Infectious Diseases | Ausgabe 1/2024

Abstract

Background

Hemophagocytic lymphohistiocytosis (HLH) is a severe disorder characterized by excessive activation of the immune system, leading to hypercytokinemia and damage to multiple organs. We report a rare case of HLH with myopericarditis caused by Campylobacter infection.

Case presentation

A 28-year-old male patient with a history of hypertension without medicine control presented at the hospital after a four-day fever, decreasing urine amount, rashes on his trunk and limbs, and other symptoms. He was admitted with a provisional diagnosis of atypical infection and allergic skin rash related to diclofenac. However, his condition deteriorated, and he developed shock, tachycardia, chest distress, and bilateral pleural effusion after admission. Further investigations revealed cardiogenic shock related to myopericarditis, and he was transferred to the ICU. In addition, a stool PCR panel subsequently revealed a positive result for Campylobacter. On day 6, he was diagnosed with HLH. Under Clarithromycin and dexamethasone infusion, leukocytosis, anemia and thrombocytopenia with cardiogenic shock status improved. Then, he was later discharged in stable condition.

Conclusions

HLH and myopericarditis caused by Campylobacter are very rare. Early detection of Campylobacter-induced HLH and multiple organ failure, as well as prompt use of antibiotics and immunosuppressants, can be helpful for prognosis.
Begleitmaterial
Hinweise

Supplementary Information

The online version contains supplementary material available at https://​doi.​org/​10.​1186/​s12879-024-09128-z.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Abkürzungen
HLH
Hemophagocytic lymphohistiocytosis
ICU
Intensive care unit
AKI
Acute kidney injury
PCR
Polymerase chain reaction

Background

Campylobacter spp. are gram-negative, short rods that thrive under microaerophilic conditions and do not form spores [1]. The most common sources of Campylobacter infection in humans are poultry, followed by beef and mutton [2]. Campylobacter is a widespread cause of bacterial gastroenteritis worldwide. Aside from gastroenteritis, Campylobacter may also cause autoimmune conditions, such as Guillain‒Barré syndrome, reactive arthritis, and irritable bowel syndrome [3]. Although infrequent, myopericarditis due to Campylobacter has been reported in some case reports [4]. Conversely, there is only one report of HLH caused by Campylobacter [5]. We present a rare case of myopericarditis concurrent with HLH caused by Campylobacter.

Case presentation

In June 2022, a 28-year-old man was referred to our hospital due to a four-day fever accompanied by a decrease in urine output. The patient had a history of hypertension but was not currently taking any medication to control it. He worked at a textile factory and had a part-time job at a poultry slaughterhouse. Three days before presenting to our hospital, the patient visited a local clinic for symptoms such as fever, headache, sore throat, epigastric pain, and diarrhea. The doctor at the clinic prescribed medications, including diclofenac and loperamide, to relieve the symptoms. However, one day later, the patient experienced vomiting, persistent fever, and new rashes on his trunk and limbs, which were not itchy, accompanied by a decrease in urine volume. Therefore, he returned to the clinic and was subsequently referred to our hospital.
Upon examination in our emergency department, the patient had a pulse rate of 130 beats per minute, a blood pressure of 142/63 mmHg, a temperature of 38.6 °C, and an oxygen saturation of 98% on room air. We observed icteric sclera and a fused, blanchable macular rash without itching on the trunk and all four limbs without mucous membrane involvement. (Fig. 1). The physical examination on the day of admission revealed a fused-macular rash distributed across the anterior and posterior trunk as well as the bilateral lower legs (Panels A, B, C). Additionally, a blanchable skin rash is present on the anterior chest, as indicated by the arrow (Panel D).) Laboratory studies showed a white blood cell count of 7100/µL, a creatinine level of 1.15 mg/dL, an elevated aspartate aminotransferase level of 66 IU/L, an alanine aminotransferase level of 104 IU/L, a total bilirubin level of 2.4 mg/dL, a direct bilirubin level of 1.2 mg/dL, a C-reactive protein level of 19.03 mg/dL (normal range < 0.4 mg/dL), and a procalcitonin level of 1.3 ng/mL (normal range 0–0.5 ng/mL) (Laboratory data collected during the hospital stay are recorded in Additional file 1: Table 1–3). We admitted the patient with a diagnosis of an atypical infection and a diclofenac-related allergic skin rash.
During the second and third days of the patient's hospitalization, he continued to experience intermittent fever of approximately 39 °C for three days, despite being treated with intravenous cefotaxime as an empirical antibiotic. He also suffered from persistent tachycardia ranging from 100/min to 140/min and chest distress with pleuritic chest pain. Shock was observed on the second night of admission, and the patient's white blood cell count increased, while hemoglobin and platelet levels decreased. Additionally, his procalcitonin and C-reactive protein levels were elevated, along with elevated troponin I and creatine kinase-myoglobin. A chest radiography revealed bilateral blunt costodiaphragmatic angle and cardiomegaly (Fig. 2). Bilateral blunting of the costophrenic angles and increased radiopacity in the right lower and middle lobes were observed, accompanied by cardiomegaly. Bilateral pleural effusion, with a predominant presence on the right side, was later confirmed by bedside echocardiography.), while an electrocardiogram showed sinus tachycardia without ST-segment and T-wave changes. A bedside echo confirmed an inferior vena cava diameter of 1.67 cm and bilateral pleural effusion. Due to his deteriorating condition, the patient's antimicrobial treatment was upgraded to intravenous teicoplanin with cefotaxime, and he was moved to the intensive care unit (ICU) because of his shock status. He was intubated and given mechanical ventilation support due to respiratory failure. In addition, he required a norepinephrine pump due to hemodynamic instability. Later, a cardiologist diagnosed the patient with myopericarditis-related cardiogenic shock based on the cardiac echo findings, which showed left ventricular global hypokinesis with 40% left ventricular ejection fraction and a small amount of pericardial effusion. On the third day, a stool polymerase chain reaction (PCR) panel revealed a positive result for Campylobacter spp. Oral Azithromycin followed by parenteral clarithromycin was administered to the patient. All other infectious workup tests, including blood culture, urine culture, FilmArray test for a pneumonia PCR panel, urine PCR and blood IgM for leptospirosis, and blood PCR, IgG, and IgM for Hanta virus and severe fever with thrombocytopenia syndrome, yielded negative results.
During the patient's stay in the ICU, they showed signs of kidney dysfunction, including reduced urine output, weight gain, and swelling in both legs that left a noticeable indentation when pressed. His hemoglobin and platelet levels dropped to their lowest points of 8.3 g/dL and 57 × 103/μl, respectively. Additionally, the patient's ferritin level was found to be 1008 ng/mL, and his triglyceride level had risen to 631 mg/dL.
On day 6, a bone marrow biopsy confirmed that the patient was suffering from hemophagocytosis (Fig. 3). The bone marrow aspirate was examined with hematoxylin and eosin stain, revealing significant phagocytosis of hematopoietic elements (arrows) and an increased number of activated macrophages at 400 × magnification.
(Fig. 4). CD68 immunohistochemistry distinctly highlights hemophagocytic histiocytes (arrows) in bone marrow biopsy specimens at 400 × magnification.), which led to a diagnosis of HLH. As a result, the patient was started on a course of dexamethasone 10 mg every 12 h.
Further tests were conducted to rule out other potential causes, such as HIV, Epstein‒Barr virus, and non-Hodgkin lymphoma, through blood and bone marrow examinations. The patient's persistent oliguria and high creatinine levels suggested sepsis and cardiorenal-related acute kidney injury (AKI). As a result, the patient underwent temporary hemodialysis on days 6, 7, and 9.
As the patient's condition improved under treatment, their dexamethasone dosage was gradually reduced, and they were weaned off the endotracheal tube. Their hemodialysis was also discontinued once their urine output increased and their creatinine levels decreased.

Discussion

Campylobacter is a type of gram-negative bacteria that can lead to food poisoning and gastroenteritis in humans. Among the different species of Campylobacter, Campylobacter jejuni is the most prevalent, causing approximately 90% of human infections worldwide, followed by Campylobacter coli [6]. These bacteria are often transmitted through the consumption of undercooked poultry, pork, beef, unpasteurized milk, and contaminated water [7]. In most cases, the infection resolves on its own without any significant consequences. However, postinfectious complications such as reactive arthritis, irritable bowel syndrome, and Guillain Barré syndrome are sometimes observed [8]. Recently, there have been some reports suggesting that Campylobacter may also be linked to rare diseases such as HLH and myocarditis.
HLH is a severe condition that occurs when cytotoxic T cells, natural killer cells, and macrophages become overactive, resulting in hypercytokinemia and damage to multiple organs. This disorder can affect people of all ages and is divided into two categories: primary HLH, which results from genetic mutations that impair the function of cytotoxic T cells and natural killer cells, and secondary HLH, which results from underlying malignancy, infection, or autoimmune disorders. HLH can present with a range of clinical and laboratory features, including fever, splenomegaly, neurological dysfunction, coagulopathy, liver dysfunction, cytopenias, hypertriglyceridemia, hyperferritinemia, hemophagocytosis, and reduced natural killer cell activity [9]. Only two cases of HLH caused by C. jejuni have been reported thus far [10, 11].
To our knowledge, there have been no reported cases of Campylobacter causing both HLH and perimyocarditis. After ruling out other possible diagnoses, we concluded that Campylobacter infection triggered an autoimmune response, resulting in the development of both HLH and perimyocarditis in our patient. This case highlights the importance of considering HLH in patients with unexplained fever and pancytopenia, as well as the potential complications of Campylobacter infection. Although HLH and myocarditis caused by Campylobacter may be rare, our experience with treatment suggests that the prompt identification of HLH and myocarditis caused by Campylobacter, as well as the timely use of steroids and antibiotics for the treatment of HLH caused by Campylobacter, can lead to a good prognosis.

Conclusion

This case report is the first documented instance of both HLH and perimyocarditis occurring simultaneously due to a Campylobacter infection. Our findings add to the existing knowledge regarding the link between Campylobacter infections and the effectiveness of steroid treatment for HLH caused by Campylobacter. As Campylobacter-related HLH and pericarditis are rare occurrences, further clinical studies and trials are necessary to improve our understanding of the underlying mechanisms and the role of Campylobacter in inducing pericarditis with HLH.

Acknowledgements

We extend our heartfelt gratitude to Dr. Jong-Shiaw Jin, Department of Pathology, Tungs' Taichung MetroHarbor Hospital, for his invaluable assistance in the selection and refinement of pathological images used in this study.

Declarations

We have concealed the patient's name and relevant information in our article. The patient has agreed to provide any information for the publication of the case report on the condition of anonymity. If necessary, we can attach the consent form along with the redacted signature.
The patient agrees to publish hisr medical record data as a case report in a medical journal for reference by the medical community.
The doctor has explained the following matters to the patient, and the patient fully understands:
1. I understand that the authors of this article and the publishing journal will make every effort to keep my personal data confidential. This case report will not contain my name and other identifiable information such as ID number, date of birth, address, etc. However, people who know me may still be able to recognize me as the patient from the content of this article.
2. I can withdraw my consent at any time before the article is published. However, once the article is submitted for publication (printed), this consent cannot be withdrawn.

Competing interests

The authors declare no competing interests.
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://​creativecommons.​org/​licenses/​by/​4.​0/​. The Creative Commons Public Domain Dedication waiver (http://​creativecommons.​org/​publicdomain/​zero/​1.​0/​) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Anhänge

Supplementary Information

Literatur
1.
Zurück zum Zitat Gharst G, Oyarzabal OA, Hussain SK. Review of current methodologies to isolate and identify Campylobacter spp. from foods. J Microbiol Methods. 2013;95(1):84–92.CrossRefPubMed Gharst G, Oyarzabal OA, Hussain SK. Review of current methodologies to isolate and identify Campylobacter spp. from foods. J Microbiol Methods. 2013;95(1):84–92.CrossRefPubMed
2.
Zurück zum Zitat Nisar M, Mushtaq MH, Shehzad W, Hussain A, Nasar M, Nagaraja KV, et al. Occurrence of campylobacter in retail meat in lahore, Pakistan. Acta Trop. 2018;185:42–5.CrossRefPubMed Nisar M, Mushtaq MH, Shehzad W, Hussain A, Nasar M, Nagaraja KV, et al. Occurrence of campylobacter in retail meat in lahore, Pakistan. Acta Trop. 2018;185:42–5.CrossRefPubMed
3.
Zurück zum Zitat Facciolà A, Riso R, Avventuroso E, Visalli G, Delia S, Laganà P. Campylobacter: from microbiology to prevention. J Prev Med Hyg. 2017;58(2):E79.PubMedPubMedCentral Facciolà A, Riso R, Avventuroso E, Visalli G, Delia S, Laganà P. Campylobacter: from microbiology to prevention. J Prev Med Hyg. 2017;58(2):E79.PubMedPubMedCentral
4.
Zurück zum Zitat Fica A, Seelmann D, Porte L, Eugenin D, Gallardo R. A case of myopericarditis associated to Campylobacter jejuni infection in the southern hemisphere. Braz J Infect Dis. 2012;16(3):294–6.CrossRefPubMed Fica A, Seelmann D, Porte L, Eugenin D, Gallardo R. A case of myopericarditis associated to Campylobacter jejuni infection in the southern hemisphere. Braz J Infect Dis. 2012;16(3):294–6.CrossRefPubMed
5.
Zurück zum Zitat Stein RA. Campylobacter jejuni and postinfectious autoimmune diseases: a proof of concept in glycobiology. ACS Infect Dis. 2022;8(10):1981–91.CrossRefPubMed Stein RA. Campylobacter jejuni and postinfectious autoimmune diseases: a proof of concept in glycobiology. ACS Infect Dis. 2022;8(10):1981–91.CrossRefPubMed
6.
Zurück zum Zitat Close encounters of the microbial kind: everything you need to know about common infections. Gastoenteritis due to campylobacter. 2021. p. 439–50. Close encounters of the microbial kind: everything you need to know about common infections. Gastoenteritis due to campylobacter. 2021. p. 439–50.
7.
Zurück zum Zitat Sahin O, Kassem II, Shen Z, Lin J, Rajashekara G, Zhang Q. Campylobacter in poultry: ecology and potential interventions. Avian Dis. 2015;59(2):185–200.CrossRefPubMed Sahin O, Kassem II, Shen Z, Lin J, Rajashekara G, Zhang Q. Campylobacter in poultry: ecology and potential interventions. Avian Dis. 2015;59(2):185–200.CrossRefPubMed
8.
Zurück zum Zitat Keithlin J, Sargeant J, Thomas MK, Fazil A. Systematic review and meta-analysis of the proportion of Campylobacter cases that develop chronic sequelae. BMC Public Health. 2014;14(1):1–19.CrossRef Keithlin J, Sargeant J, Thomas MK, Fazil A. Systematic review and meta-analysis of the proportion of Campylobacter cases that develop chronic sequelae. BMC Public Health. 2014;14(1):1–19.CrossRef
9.
Zurück zum Zitat Al-Samkari H, Berliner N. Hemophagocytic lymphohistiocytosis. Annu Rev Pathol. 2018;13:27–49.CrossRefPubMed Al-Samkari H, Berliner N. Hemophagocytic lymphohistiocytosis. Annu Rev Pathol. 2018;13:27–49.CrossRefPubMed
10.
Zurück zum Zitat Dubuc CE, Cáceres VA, Villalba CM, Uriarte ME, Rubio IH, Otano JB. THU0452 secondary hemophagocytic lymphohistiocytosis: a series of 11 patients. literature review. Ann Rheum Dis. 2013;72(Suppl 3):A317. Dubuc CE, Cáceres VA, Villalba CM, Uriarte ME, Rubio IH, Otano JB. THU0452 secondary hemophagocytic lymphohistiocytosis: a series of 11 patients. literature review. Ann Rheum Dis. 2013;72(Suppl 3):A317.
11.
Zurück zum Zitat Shi FE, Chen MF, Li YJ, Dong GY, Zhu JH. Campylobacter jejuni-associated hemophagocytic lymphohistiocytosis and guillain-barre syndrome: a case report. Front Med. 2022;9:895923.CrossRef Shi FE, Chen MF, Li YJ, Dong GY, Zhu JH. Campylobacter jejuni-associated hemophagocytic lymphohistiocytosis and guillain-barre syndrome: a case report. Front Med. 2022;9:895923.CrossRef
Metadaten
Titel
Hemophagocytic lymphohistiocytosis and myopericarditis induced by campylobacter: a case report
verfasst von
Chia Hua Chang
Chih-Chuan Kao
Publikationsdatum
01.12.2024
Verlag
BioMed Central
Erschienen in
BMC Infectious Diseases / Ausgabe 1/2024
Elektronische ISSN: 1471-2334
DOI
https://doi.org/10.1186/s12879-024-09128-z

Weitere Artikel der Ausgabe 1/2024

BMC Infectious Diseases 1/2024 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Reizdarmsyndrom: Diäten wirksamer als Medikamente

29.04.2024 Reizdarmsyndrom Nachrichten

Bei Reizdarmsyndrom scheinen Diäten, wie etwa die FODMAP-arme oder die kohlenhydratreduzierte Ernährung, effektiver als eine medikamentöse Therapie zu sein. Das hat eine Studie aus Schweden ergeben, die die drei Therapieoptionen im direkten Vergleich analysierte.

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.